Hip
Senior Member
- Messages
- 18,109
I have been taking very low doses (12.5 mg daily) of the drug amisulpride for around a year now, and I have found this drug quite helpful for a number of mental and cognitive symptoms that arise in ME/CFS and its comorbid conditions like depression and anxiety disorder.
At very low doses, amisulpride is know to act as an:
Antidepressant treatment
Anti-anhedonia treatment
Anti-anxiety treatment
I have personally found that very low-dose amisulpride also:
Reduces ME/CFS noise sensitivity symptoms
Greatly reduces ME/CFS irritability symptoms
Improves sociability
Treats mild psychosis symptoms
Improves attention deficit-hyperactivity disorder (ADHD)
I have all the above conditions, and so I found amisulpride particularly useful.
This small scale study of the benefits of amisulpride for ME/CFS found that 25 mg of this drug taken twice daily reduced fatigue and somatic complaints, such as pain.
Amisulpride is not licensed in the US, but it can be obtained from the usual overseas suppliers. I believe the smallest available size of amisulpride tablets is 50 mg, so you will need to cut these 50 mg tablets in half or in quarters if you want to take the very lowest doses of 25 mg and 12.5 mg.
I find 12.5 mg is a good dose for me; if I go up to 25 mg, it seems to make me a bit torpid and unmotivated.
UPDATE: Dopamine system stabilization drugs (third-generation antipsychotics) such as amisulpride (Solian) aripiprazole (Abilify) have been shown to benefit ME/CFS when taken in combination with an antidepressant — see this post. Amisulpride was the original third-generation antipsychotic. Ref: 1
A dopamine system stabilizer acts as an agonist of the dopamine receptors at low dopamine concentrations, but acts as an antagonist at high dopamine concentrations. So it boosts the dopamine system when dopamine is low, but puts the breaks on the system when dopamine is high. Refs: 1 2
My theory as to why dopamine stabilizer drugs are helpful for ME/CFS is here.
This paper indicates the two mechanisms of dopamine stabilization:
Aripiprazole (Abilify) comes under the first mechanism, as it is a partial agonist with affinity for dopamine autoreceptors; and amisulpride comes under the second mechanism.
The response to amisulpride is also dose-level dependent:
At low doses, amisulpride blocks the dopamine autoreceptors. An autoreceptor is presynaptic regulatory feedback mechanism which controls how much of a neurotransmitter like dopamine is being released into the synapse (the junction between neurons). When you block the dopamine autoreceptors, it makes the neuron think there is not enough dopamine in the synapse, so more dopamine is released. In this way, blocking dopamine autoreceptors leads to more dopamine release.
But at high doses of amisulpride, then this drug starts to antagonize the postsynaptic dopamine receptor (the normal dopamine receptor), and at these higher doses the overall effect is dopamine antagonism. Refs: 1 2
This study says:
Aripiprazole behaves similarly at the presynaptic and postsynaptic dopamine receptors. This paper says:
Aripiprazole's dopamine stabilization is described here:
Note that amisulpride is not the only antipsychotic that may show benefit in ME/CFS: quetiapine (Seroquel) is also used in ME/CFS and fibromyalgia for treating pain and improving sleep (as well as helping depression ).
There are serious side effects that can result from taking antipsychotics, such as extrapyramidal symptoms like tardive dyskinesia. And developing type 2 diabetes is a risk too. But on the low-dose protocols of amisulpride or Abilify, the risks of these side effects are very much less. Refs: here and here.
BUYING AMISULPRIDE:
Amisulpride can be bought prescription-free from any of the following pharmacies:
InHouse, United Pharmacies, United Pharmacies UK, International Drug Mart, GoldPharma, 4RNX, 4NRX UK, Pharmacy Geoff, Buy Pharma, ClearSky Pharmacy, Over-the-Counter.
Other prescription-free pharmacies where amisulpride can be bought listed in this post.
At very low doses, amisulpride is know to act as an:
Antidepressant treatment
Anti-anhedonia treatment
Anti-anxiety treatment
I have personally found that very low-dose amisulpride also:
Reduces ME/CFS noise sensitivity symptoms
Greatly reduces ME/CFS irritability symptoms
Improves sociability
Treats mild psychosis symptoms
Improves attention deficit-hyperactivity disorder (ADHD)
I have all the above conditions, and so I found amisulpride particularly useful.
This small scale study of the benefits of amisulpride for ME/CFS found that 25 mg of this drug taken twice daily reduced fatigue and somatic complaints, such as pain.
Amisulpride is not licensed in the US, but it can be obtained from the usual overseas suppliers. I believe the smallest available size of amisulpride tablets is 50 mg, so you will need to cut these 50 mg tablets in half or in quarters if you want to take the very lowest doses of 25 mg and 12.5 mg.
I find 12.5 mg is a good dose for me; if I go up to 25 mg, it seems to make me a bit torpid and unmotivated.
UPDATE: Dopamine system stabilization drugs (third-generation antipsychotics) such as amisulpride (Solian) aripiprazole (Abilify) have been shown to benefit ME/CFS when taken in combination with an antidepressant — see this post. Amisulpride was the original third-generation antipsychotic. Ref: 1
A dopamine system stabilizer acts as an agonist of the dopamine receptors at low dopamine concentrations, but acts as an antagonist at high dopamine concentrations. So it boosts the dopamine system when dopamine is low, but puts the breaks on the system when dopamine is high. Refs: 1 2
My theory as to why dopamine stabilizer drugs are helpful for ME/CFS is here.
This paper indicates the two mechanisms of dopamine stabilization:
Partial agonists that display affinity for dopamine autoreceptors are potential stabilisers of dysregulated dopamine release in schizophrenia (Grunder et al, 2003).
However, it has been suggested that dopamine autoreceptor antagonists (sulpiride and amisulpride) also stabilise dopamine systems in schizophrenia by increasing dopamine release and selectively blocking D2 and D3 receptors in the limbic system (Kerwin, 2000).
Aripiprazole (Abilify) comes under the first mechanism, as it is a partial agonist with affinity for dopamine autoreceptors; and amisulpride comes under the second mechanism.
The response to amisulpride is also dose-level dependent:
At low doses, amisulpride blocks the dopamine autoreceptors. An autoreceptor is presynaptic regulatory feedback mechanism which controls how much of a neurotransmitter like dopamine is being released into the synapse (the junction between neurons). When you block the dopamine autoreceptors, it makes the neuron think there is not enough dopamine in the synapse, so more dopamine is released. In this way, blocking dopamine autoreceptors leads to more dopamine release.
But at high doses of amisulpride, then this drug starts to antagonize the postsynaptic dopamine receptor (the normal dopamine receptor), and at these higher doses the overall effect is dopamine antagonism. Refs: 1 2
This study says:
At low doses, amisulpride (100 mg/die or less) preferentially blocks presynaptic dopamine autoreceptors that control dopamine synthesis and release; whereas, at higher doses, it presents postsynaptic dopamine D2-receptor antagonism.
Aripiprazole behaves similarly at the presynaptic and postsynaptic dopamine receptors. This paper says:
There is evidence that aripiprazole functions as both a presynaptic D2 agonist and post synaptic D2 antagonist. Presynaptic D2 autoreceptors may play a vital role in the ability of aripiprazole to act as a DA system stabilizer, but at higher doses (such as the ones used to treat schizophrenia), aripiprazole also has a significant binding affinity at post synaptic D2 receptors.
Aripiprazole's dopamine stabilization is described here:
At high dopamine concentrations, aripiprazole lowers dopamine neuronal firing, while at low concentrations it increases dopamine firing. At the time, this mechanism of action was called ‘dopamine stabilization’ because a single drug could increase or decrease neuronal firing as needed.
Note that amisulpride is not the only antipsychotic that may show benefit in ME/CFS: quetiapine (Seroquel) is also used in ME/CFS and fibromyalgia for treating pain and improving sleep (as well as helping depression ).
There are serious side effects that can result from taking antipsychotics, such as extrapyramidal symptoms like tardive dyskinesia. And developing type 2 diabetes is a risk too. But on the low-dose protocols of amisulpride or Abilify, the risks of these side effects are very much less. Refs: here and here.
BUYING AMISULPRIDE:
Amisulpride can be bought prescription-free from any of the following pharmacies:
InHouse, United Pharmacies, United Pharmacies UK, International Drug Mart, GoldPharma, 4RNX, 4NRX UK, Pharmacy Geoff, Buy Pharma, ClearSky Pharmacy, Over-the-Counter.
Other prescription-free pharmacies where amisulpride can be bought listed in this post.
Amisulpride : A forgotten "Old-School" AntiPsychotic with A Superior Anti-Depressant Profile & Unique Mechanism of Action (Little to no Side Effects)
Amisulpride certainly doesn't carry the wide array of pharmacological actions that most "familiar" or "Atypical Antipsychotics" do, but that doesn't make it any less potent (1).
AMISULPRIDE HAS FAR LESS SIDE-EFFECTS
One distinguishable trait of amisulpride is that lower doses seem to only, or mostly block the dopamine D2S (autoreceptors) (2) - which leads to an actual enhancement in dopamine release (3).
Most of the usual antipsychotics we hear about, e.g risperidone, thorazine and Haldol — all have very potent dual action dopamine receptor blockade (4). This leads to many more side-effects, including incidences of depression and high rates of drug-induced tardive dyskinesia (5).
Additionally, most anti-psychotic drugs have extremely potent alpha-1-adrenergic receptor blockade (6) (7), amisulpride lacks this property, as well as the usual anti histamine property of anti-psychotics (8) — which means AmiSulpride is very unlikely to cause any form of sedation (9).
Usually, the anti-histamine properties of other anti-psychotic drugs combined with the alpha-1-blockade — acts as a one-two punch in knocking the patient out cold.... frequently we hear about some of the affected even drooling on themselves or just completely incoherent and lethargic the following day (10)!
While some medical professionals consider this a benefit in hostile or unpredictable patients, I would find it much less than ideal for someone who wants to maintain somewhat of a normal life, not incapacitated but with symptoms controlled (11).
Besides lack of side-effects, or at least lack of sedation, amisulpride has one very notable effect that sets it apart from other drugs in its class — its anti-depressant effects are VERY FAST ACTING, very potent — and generally yield little to no negative endocrine effects (12).
The mechanism of action is totally unique, amisulpride binds to the serotonin 5-HT(7) with 11.5 nanomolar (ki/nm) affinity - this includes in human subjects (14).
It antagonizes the action of serotonin at this receptor — resulting in an anti-depressant effect that cannot only augment other anti-depressants — but can be much more effective alone than many anti-depressants (15).
The additional benefits of 5-HT(7) antagonism are that it will reduce overstimulation and anxiety - as well as treat depression - and lower cortisol levels as well (16).
Because many depressed patients exhibit HPAA (hypothalamic-pituitary-adrenal-axis) dysfunction — and often have elevated cortisol — this unique mechanism of action may benefit the hormonal balance of depressed patients (17), unlike SSRIs which tend to increase stress hormones (18) and oppose other beneficial neurotransmitters such as GABA, dopamine and others (19)!
Thus, in summary...
Amisulpride has the following benefits / advantages over other drugs aiming to do the same.
Source: TrueLife Research
Amisulpride certainly doesn't carry the wide array of pharmacological actions that most "familiar" or "Atypical Antipsychotics" do, but that doesn't make it any less potent (1).
AMISULPRIDE HAS FAR LESS SIDE-EFFECTS
One distinguishable trait of amisulpride is that lower doses seem to only, or mostly block the dopamine D2S (autoreceptors) (2) - which leads to an actual enhancement in dopamine release (3).
Most of the usual antipsychotics we hear about, e.g risperidone, thorazine and Haldol — all have very potent dual action dopamine receptor blockade (4). This leads to many more side-effects, including incidences of depression and high rates of drug-induced tardive dyskinesia (5).
Additionally, most anti-psychotic drugs have extremely potent alpha-1-adrenergic receptor blockade (6) (7), amisulpride lacks this property, as well as the usual anti histamine property of anti-psychotics (8) — which means AmiSulpride is very unlikely to cause any form of sedation (9).
Usually, the anti-histamine properties of other anti-psychotic drugs combined with the alpha-1-blockade — acts as a one-two punch in knocking the patient out cold.... frequently we hear about some of the affected even drooling on themselves or just completely incoherent and lethargic the following day (10)!
While some medical professionals consider this a benefit in hostile or unpredictable patients, I would find it much less than ideal for someone who wants to maintain somewhat of a normal life, not incapacitated but with symptoms controlled (11).
Besides lack of side-effects, or at least lack of sedation, amisulpride has one very notable effect that sets it apart from other drugs in its class — its anti-depressant effects are VERY FAST ACTING, very potent — and generally yield little to no negative endocrine effects (12).
The mechanism of action is totally unique, amisulpride binds to the serotonin 5-HT(7) with 11.5 nanomolar (ki/nm) affinity - this includes in human subjects (14).
It antagonizes the action of serotonin at this receptor — resulting in an anti-depressant effect that cannot only augment other anti-depressants — but can be much more effective alone than many anti-depressants (15).
The additional benefits of 5-HT(7) antagonism are that it will reduce overstimulation and anxiety - as well as treat depression - and lower cortisol levels as well (16).
Because many depressed patients exhibit HPAA (hypothalamic-pituitary-adrenal-axis) dysfunction — and often have elevated cortisol — this unique mechanism of action may benefit the hormonal balance of depressed patients (17), unlike SSRIs which tend to increase stress hormones (18) and oppose other beneficial neurotransmitters such as GABA, dopamine and others (19)!
Thus, in summary...
Amisulpride has the following benefits / advantages over other drugs aiming to do the same.
- A cortisol reduction, instead of increase.
- Enhances dopamine at lower doses.
- Little to no sedation, drowsiness, dyskinesia, tremors , punding or other disturbing side-effects.
- Doesn't interfere with cognitive function or vigilance.
- Treats depression quickly , and effectively.
- May improve anxiety symptoms as well.
Source: TrueLife Research
Last edited: